The cases with coexistence of coronary artery disease and peripheral arterial disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The coronary artery disease (CAD) patient who has a peripheral artery disease (PAD). PAD (1)ABI < 0.9 (2)Fontaine classification >= II (3) previous revascularization in lower limbs (4) occlusive arteries in lower limbs by imaging examinations CAD as the presence of >= 50% narrowing of coronary artery diameter in at least one major coronary artery
Exclusion criteria
Exclusion criteria: (1)heart failure with reduced left ventricular systolic function (ejection fraction<50%) (2)severe valvular heart disease(3)cardiomyopathy (4)systemic illness [including advanced endocrine, hepatic, or renal diseases (5)active inflammatory diseases (6)cancer (7)with residual hemiplegia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| endothelial evaluation of function by reactive hyperemia peripheral arterial tonometry | — |
Secondary
| Measure | Time frame |
|---|---|
| The effect of Cilostazol to the peripheral artery disease patients | — |
Countries
Japan